A detailed history of Pnc Financial Services Group, Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 199 shares of KOD stock, worth $1,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199
Previous 199 -0.0%
Holding current value
$1,303
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.4 - $3.24 $278 - $644
199 New
199 $0
Q2 2022

Aug 12, 2022

SELL
$5.04 - $9.48 $433 - $815
-86 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$7.09 - $89.45 $609 - $7,692
86 New
86 $0
Q4 2021

Feb 11, 2022

SELL
$80.85 - $128.49 $4,042 - $6,424
-50 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$81.97 - $106.94 $3,278 - $4,277
40 Added 400.0%
50 $4,000
Q2 2021

Aug 06, 2021

BUY
$77.2 - $126.54 $77 - $126
1 Added 11.11%
10 $0
Q1 2021

May 07, 2021

BUY
$110.45 - $164.47 $994 - $1,480
9 New
9 $1,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $341M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.